A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery

Part of paid clinical trials in San Diego, California.

Sponsor
Alume Biosciences, Inc.
Study ID
NCT06662097
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Imaging
  • Nerve Injury
  • Surgery

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Bevonescein — DRUG
    Bevonescein is a sterile solution that is intravenously administered

Study Details

Feasibility study of Bevonescein to highlight Nerves and Ureter in patients undergoing Minimally Invasive Surgery

Key Dates

Start date
Oct 16, 2024
Status verified
Oct 2024
Primary completion
Jun 30, 2025
Completion
Sep 30, 2025

Study Design

Enrollment
64 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION

Arms

  • Experimental: Dose Defining
    A dose defining phase for each surgical setting.
  • Experimental: Dose Expansion
    A dose expansion phase for each surgical setting.

Primary Outcome Measure

Fluorescence System Survey [ Time Frame: 28 (+5 days) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California San DiegoSan DiegoCalifornia92037
Principal Investigator

Find similar trials in San Diego, CA

By research site
University of California San Diego· San Diego, CA

Related Studies